Comment on: Should metabolic surgery be offered in morbidly obese patients with type i diabetes?

Surgery for Obesity and Related Diseases

Volumn 11, Issue 4, 2015, Pages 805-807

  Cohen, Ricardo ^a  

^a Forensic Toxicology Laboratory   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CARDIOVASCULAR RISK; CELL FUNCTION; DIABETES CONTROL; EDITORIAL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORBID OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ROUX EN Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; STOMACH BYPASS; TREATMENT INDICATION; COMPLICATION; FEMALE; MALE; OBESITY, MORBID; PROCEDURES; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; OBESITY, MORBID; WEIGHT LOSS;

EID: 84938198005     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2015.01.020     Document Type: Editorial

References (17)

1. Robert M, Belanger P, Hould FS, Marceau S, Tchernof A, Biertho L. Should metabolic surgery be offered in morbidly obese patients with type I diabetes? Surg Obes Relat Dis. 2015;11(4)799-806.
2. S. Halimi, and P.Y. Benhamou Diabetes, a worldwide disease Presse Med. 33 2004 37 40
3. P. Murray, G.W. Chune, and V.A. Raghavan Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials Curr Atheroscler Rep 12 6 2010 432 439
4. S.A. Brethauer, A. Aminian, R.J. Rosenthal, J.P. Kirwan, S.R. Kashyap, and P.R. Schauer Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes Diabetes Care 37 3 2014 20 e51 e52
5. U. Kielgast, T. Krarup, J.J. Holst, and S. Madsbad Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual ß cell function Diabetes Care 34 7 2011 27 1463 1468
6. R.S. Rao, and S. Kini Diabetic and bariatric surgery: a review of the recent trends Surg Endosc 26 4 2012 893 903
7. T.T. Søvik, E.T. Aasheim, O. Taha, and et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial Ann Intern Med. 155 5 2011 281 291
8. D.M. Breen, B.A. Rasmussen, A. Kokorovic, R. Wang, G.W.C. Cheung, and T.K.T. Lam Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes Nat Med 20 2012 1 7
9. A. Lindqvist, P. Spégel, M. Ekelund, and et al. Gastric bypass improves ß-cell function and increases β-cell mass in a porcine model Diabetes 63 5 2014 1665 1671
10. W.-J. Lee, K. Chong, K.-H. Ser, and et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial Arch Surg 146 2 2011 143 148
11. P.R. Schauer, S.R. Kashyap, K. Wolski, and et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes N Engl J Med 366 17 2012 1567 1576
12. P.R. Schauer, D.L. Bhatt, J.P. Kirwan, and et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes N Engl J Med 370 21 2014 2002 2013
13. A. de Hollanda, T. Ruiz, A. Jiménez, L. Flores, A. Lacy, and J. Vidal Patterns of weight loss response following gastric bypass and sleeve gastrectomy Obes Surg. Epub 2014 Nov 25
14. R. Cohen Sleeve gastrectomy: the ideal option for metabolic surgery? Nat Rev Endocrinol 9 10 2013 623
15. A.K. Davis, S.N. DuBose, M.J. Haller, and et al. Prevalence of detectable C-peptide According to age at diagnosis and duration of type 1 diabetes Diabetes Care. Epub 2014 Dec 17
16. C.J. Greenbaum, A.M. Anderson, L.M. Dolan, and et al. Preservation of cell function in autoantibody-positive youth with diabetes Diabetes Care 32 10 2009 1839 1844
17. B. Laferrere, S. Heshka, and K. Wang Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 2007 1709 1716